The anemia-independent impact of myelodysplastic syndromes on health-related quality of life
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0584
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The anemia-independent impact of myelodysplastic syndromes on health-related quality of life ; volume:100 ; number:12 ; day:2 ; month:9 ; year:2021 ; pages:2921-2932 ; date:12.2021
Annals of hematology ; 100, Heft 12 (2.9.2021), 2921-2932, 12.2021
- Urheber
-
Wouters, Hanneke J. C. M.
Conrads-Frank, Annette
Koinig, Karin A.
Smith, Alex
Yu, Ge
Witte, Theo de
Wolffenbuttel, Bruce H. R.
Huls, Gerwin
Siebert, Uwe
Stauder, Reinhard
Klauw, Melanie M. van der
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-021-04654-1
- URN
-
urn:nbn:de:101:1-2022012521514797764690
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wouters, Hanneke J. C. M.
- Conrads-Frank, Annette
- Koinig, Karin A.
- Smith, Alex
- Yu, Ge
- Witte, Theo de
- Wolffenbuttel, Bruce H. R.
- Huls, Gerwin
- Siebert, Uwe
- Stauder, Reinhard
- Klauw, Melanie M. van der
- SpringerLink (Online service)
Ähnliche Objekte (12)
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Drug development in higher-risk myelodysplastic syndromes
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea
Genomics of myelodysplastic syndromes in children and adolescents
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Drug development in higher-risk myelodysplastic syndromes
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea
Genomics of myelodysplastic syndromes in children and adolescents
Myelodysplastic syndromes
Myelodysplastic syndromes
Epigenetic therapy in myelodysplastic syndromes
Myelodysplastic syndromes : with 87 tabeles
Bone marrow apoptosis in myelodysplastic syndromes
Emerging Therapies for the Myelodysplastic Syndromes
Myelodysplastic syndromes: Where do we stand?
Bone marrow apoptosis in myelodysplastic syndromes
Myelodysplastic syndromes current treatment algorithm 2018
Drug development in higher-risk myelodysplastic syndromes
Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea